DE602005024923D1 - Wässrige lösung mit einem camptothecin - Google Patents

Wässrige lösung mit einem camptothecin

Info

Publication number
DE602005024923D1
DE602005024923D1 DE602005024923T DE602005024923T DE602005024923D1 DE 602005024923 D1 DE602005024923 D1 DE 602005024923D1 DE 602005024923 T DE602005024923 T DE 602005024923T DE 602005024923 T DE602005024923 T DE 602005024923T DE 602005024923 D1 DE602005024923 D1 DE 602005024923D1
Authority
DE
Germany
Prior art keywords
aqueous solution
camptothecin
camptothecins
preparation containing
solution preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024923T
Other languages
English (en)
Inventor
Masako Nakazawa
Ritsuo Aiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of DE602005024923D1 publication Critical patent/DE602005024923D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
DE602005024923T 2004-02-13 2005-02-09 Wässrige lösung mit einem camptothecin Active DE602005024923D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004035985 2004-02-13
JP2004035986 2004-02-13
PCT/JP2005/001902 WO2005077370A1 (ja) 2004-02-13 2005-02-09 カンプトテシン類含有水溶液製剤

Publications (1)

Publication Number Publication Date
DE602005024923D1 true DE602005024923D1 (de) 2011-01-05

Family

ID=34863456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024923T Active DE602005024923D1 (de) 2004-02-13 2005-02-09 Wässrige lösung mit einem camptothecin

Country Status (8)

Country Link
US (1) US20080242691A1 (de)
EP (1) EP1714653B1 (de)
JP (1) JP4451850B2 (de)
AT (1) ATE489094T1 (de)
CA (1) CA2556254A1 (de)
DE (1) DE602005024923D1 (de)
TW (1) TW200538457A (de)
WO (1) WO2005077370A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110177161A1 (en) * 2007-05-24 2011-07-21 Dr. Reddy's Laboratories Limited Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin
CA2758122C (en) * 2008-04-11 2017-05-16 Zhijun Liu Diterpene glycosides as natural solubilizers
WO2010151653A2 (en) 2009-06-24 2010-12-29 Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College Terpene glycosides and their combinations as solubilizing agents
US10098813B2 (en) 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
JP4094710B2 (ja) * 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US6476043B1 (en) 1998-08-05 2002-11-05 Aventis Pharma S.A. Use of camptothecin derivatives, with reduced gastrointestinal toxicity
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
ES2358639T3 (es) * 2000-03-09 2011-05-12 Yale University Composición que consiste en phy906 y agentes quimioterapéuticos.
US6653319B1 (en) * 2001-08-10 2003-11-25 University Of Kentucky Research Foundation Pharmaceutical formulation for poorly water soluble camptothecin analogues
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
JP4245384B2 (ja) 2003-03-18 2009-03-25 株式会社ヤクルト本社 カンプトテシン類含有医薬組成物

Also Published As

Publication number Publication date
EP1714653A4 (de) 2008-05-21
JPWO2005077370A1 (ja) 2007-10-18
WO2005077370A8 (ja) 2006-01-05
EP1714653B1 (de) 2010-11-24
US20080242691A1 (en) 2008-10-02
TW200538457A (en) 2005-12-01
CA2556254A1 (en) 2005-08-25
WO2005077370A1 (ja) 2005-08-25
EP1714653A1 (de) 2006-10-25
JP4451850B2 (ja) 2010-04-14
ATE489094T1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
ATE430558T1 (de) Herstellung von mikrokügelchen
DE602006017057D1 (de) Dehydracetsäure enthaltende hautpflegezusammensetzungen mit niedrigem ph
WO2007005633A8 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
HK1107922A1 (en) Suture with adhesive/sealant delivery mechanism
NZ609469A (en) Improved high concentration anti-tnfα antibody liquid formulations
DE602004005073D1 (de) Verbesserte kosmetische zusammensetzung mit vitamin b3, vitamin b6 und einer organischen säure
WO2006079641A3 (en) Insulin derivatives conjugated with structurally well defined branched polymers
EP1595884A3 (de) Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen
YU2003A (sh) Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama
EP1679071A4 (de) Kollagen-produktionsverstärker und herstellungsverfahren und verwendung
DE602005024923D1 (de) Wässrige lösung mit einem camptothecin
WO2009019835A1 (ja) 生薬エキス配合液剤
IL161390A0 (en) Ready-to-use- paracetamol injection solutions containing propylene glycol as the only cosolvent
DE50000275D1 (de) Verfahren zur Ringspaltung von Thiazolidinderivaten
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
WO2008074488A3 (en) Construction and use of transfection enhancer elements
WO2003094905A8 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
DE60101859D1 (de) Pinolensäure gegen Diabetes
WO2008053206A3 (en) Process for preparation of aldonic acids and derivatives thereof
WO2008040987A3 (en) Biocidal formulation
TW200727900A (en) Aqueous solution preparation containing camptothecins
ATE367738T1 (de) Herbizide zusammensetzung und verwendung
SG106142A1 (en) Process for the preparation of stabilized polycarbonate
CN201219456Y (zh) 易点着灭蚊香
CN202579521U (zh) 钉子